1832 Asset Management L.P. Astrazeneca PLC Transaction History
1832 Asset Management L.P.
- $52.9 Billion
- Q2 2025
A detailed history of 1832 Asset Management L.P. transactions in Astrazeneca PLC stock. As of the latest transaction made, 1832 Asset Management L.P. holds 29,269 shares of AZN stock, worth $2.46 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
29,269
Previous 10,726
172.88%
Holding current value
$2.46 Million
Previous $788,000
159.52%
% of portfolio
0.0%
Previous 0.0%
Shares
26 transactions
Others Institutions Holding AZN
# of Institutions
1,446Shares Held
497MCall Options Held
7.22MPut Options Held
2.57M-
Price T Rowe Associates Inc Baltimore, MD51.9MShares$4.37 Billion0.41% of portfolio
-
Primecap Management CO Pasadena, CA41.2MShares$3.46 Billion2.35% of portfolio
-
Wellington Management Group LLP Boston, MA34.3MShares$2.89 Billion0.45% of portfolio
-
Capital International Investors Los Angeles, CA31.4MShares$2.64 Billion0.39% of portfolio
-
Bank Of America Corp Charlotte, NC31.2MShares$2.62 Billion0.16% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $261B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...